Welcome to the HCV Advocate’s DDW Conference coverage.  In an effort to best serve our readership, we will post all the important and interesting abstracts about HCV from the conference.  While attending the conference, we will update any abstracts that we personally cover at the conference. The updated abstracts will be marked with the date that they have been updated and posted.  The other abstracts posted to the web site are HCV related abstracts posted to www.ddw.org that we have not been able to report on or update.  


To locate specific abstracts on this page, click on “Edit” at the top of  your browser (Microsoft Internet Explorer) and then on Find (on this page).  In Netscape, click on “Search” and then on “Find in This Page.” Simply type in a word or term and the search engine will list the related abstracts.


Please click here to view our fact sheet on reading and understanding an abstract.


Thank You,

Alan Franciscus







Hepatitis C


Acute Hepatitis C - Treatment

Current Therapies-

·         Interim Analysis Of a Randomized, Controlled Study Comparing the Efficacy Of 40KD Peg-Interferon Alfa2a in Combination With 800mg or 400 Mg Ribavirin/day in Chronic Hepatitis C, Genotype 2/3

·         Treatment With Combination Peginterferon Alfa-2b And ribavirin Of Recurrent Hepatitis C in Liver Transplant recipients Nonresponsive To Interferon Alfa-2b And ribavirin

Diagnostic Tools –


Disease Management


Disease Progression–



o       Veterans


Experimental Therapies–


Extrahepatic Manifestations–









Predicting Treatment Response–


Quality of Life–




Side Effect Management


Special Populations–









Viral Kinetics–


Weight-Based Dosing–





HIV/HCV Coinfection


Diagnostic Tools–


Disease Progression–


Predicting Treatment Response


Side Effects


Special Populations–







HBV/HCV Coinfection